person

Ray M.

Country
Ireland
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
293
Sites with multiple studies

Has run more than one trial at 293 of 550 partner sites.

Specializations

Advanced Solid Tumor Oncology

Focus on metastatic and high‑risk solid tumors across multiple organ systems, spanning adjuvant to refractory disease stages.

  • Metastatic prostate cancer
  • Advanced renal cell carcinoma
  • Advanced non‑small cell lung cancer
  • Advanced breast cancer
  • Advanced urothelial carcinoma
  • Advanced colorectal cancer
  • Advanced gastric cancer
  • Advanced pancreatic adenocarcinoma
  • Advanced melanoma
  • Advanced bladder cancer

Investigations address disease‑free survival, overall survival, and biomarker‑guided therapeutic stratification.

Hematologic Malignancies

Research spanning acute, chronic, and lymphoid neoplasms with emphasis on novel targeted and immunologic approaches.

  • Acute myeloid leukemia
  • Diffuse large B‑cell lymphoma
  • Newly diagnosed multiple myeloma
  • Myelodysplastic syndromes
  • Treatment‑naïve chronic lymphocytic leukemia

Efforts include evaluation of disease‑specific survival endpoints and integration of molecular profiling.

Immunotherapy and Targeted Therapeutics

Development of checkpoint inhibition, kinase inhibition, and biomarker‑directed strategies across tumor types.

  • PD‑1/PD‑L1 checkpoint inhibition
  • KRAS G12C targeted therapy
  • HER2‑directed therapy
  • FGFR‑targeted agents
  • CDK4/6 inhibition
  • PARP inhibition
  • CTLA‑4 blockade

Combination regimens with chemotherapy or radiation are evaluated for synergistic efficacy.

Respiratory and Pulmonary Disorders

Clinical investigations targeting chronic airway and interstitial lung diseases to reduce exacerbations and improve function.

  • Severe asthma
  • Chronic obstructive pulmonary disease
  • Idiopathic pulmonary fibrosis
  • Autoimmune pulmonary alveolar proteinosis
  • Bronchiectasis

Endpoints include rate of moderate‑to‑severe exacerbations and preservation of lung capacity.

Neurodegenerative and Cognitive Disorders

Studies aiming to modify disease trajectory and preserve cognition in Alzheimer‑related conditions.

  • Dominantly inherited Alzheimer disease
  • Mild cognitive impairment
  • Alzheimer’s‑type dementia
  • Early Alzheimer’s disease
  • Down syndrome‑associated Alzheimer’s disease

Assessments focus on cognitive rating scales and biomarkers of neurodegeneration.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.